Valuation: Optiscan Imaging Limited

Market Cap 125M 88.5M 76.55M 71.49M 65.58M 123M 8.42B 839M 329M 4.22B 332M 325M 13.96B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 86.33M 74.67M 69.73M 63.97M 120M 8.22B 818M 321M 4.12B 324M 317M 13.61B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 day+6.25%
1 week+17.24%
Current month+17.24%
1 month+9.68%
3 months+61.90%
6 months+100.00%
Current year+70.00%
1 week 0.14
Extreme 0.145
0.17
1 month 0.14
Extreme 0.14
0.17
Current year 0.08
Extreme 0.08
0.17
1 year 0.08
Extreme 0.079
0.17
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 13/12/2021
Director of Finance/CFO - 31/03/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 10/02/2021
Chairman - 19/04/2021
Director/Board Member - 06/05/2021
Date Insider Type Main position Quantity % Market Cap.
15/01/26 Free

Director

230,502 0.0221%
15/01/26 Free

Chairman

419,094 0.0401%
15/01/26 Free

Chief Executive Officer

6,157,719 0.5897%
Change 5-day change 1-year change 3-year change Capi.($)
+6.25%+17.24%+78.95%+115.19% 125M
+1.40%-2.57%-13.89%-16.69% 13.68B
+5.40%+14.67%+52.69%+5.80% 4.47B
+1.25%+0.44%-38.58%-52.54% 1.28B
0.00%+1.50%-34.34%-38.22% 1.2B
+1.41%+1.80%+32.27%+91.58% 1.18B
+2.07%+1.53%-44.10% - 968M
+7.65%+24.10%+54.44%+165.49% 622M
+2.90%+7.90%+80.66% - 355M
+1.36%-2.28%-60.43%+236.81% 259M
Average +2.97%+6.98%+10.77%+63.43% 2.41B
Weighted average by Cap. +2.30%+2.13%+0.31%-1.24%

Financials

2024 2025
Net sales 2.99M 2.11M 1.82M 1.7M 1.56M 2.94M 201M 19.99M 7.84M 101M 7.92M 7.75M 333M 3.72M 2.63M 2.28M 2.12M 1.95M 3.67M 250M 24.93M 9.78M 125M 9.88M 9.66M 415M
Net income -6.06M -4.28M -3.7M -3.46M -3.17M -5.97M -407M -40.57M -15.92M -204M -16.07M -15.72M -675M -6.31M -4.46M -3.86M -3.6M -3.3M -6.21M -424M -42.25M -16.58M -213M -16.74M -16.37M -703M
Net Debt -11.01M -7.78M -6.73M -6.28M -5.76M -10.84M -740M -73.7M -28.93M -371M -29.2M -28.56M -1.23B -3.07M -2.17M -1.88M -1.75M -1.61M -3.02M -206M -20.55M -8.07M -103M -8.14M -7.97M -342M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
07/08/26 A$0.1700 +6.25% 160,906
06/08/26 A$0.1600 0.00% 231,426
05/08/26 A$0.1600 +3.23% 115,333
04/08/26 A$0.1550 +6.90% 165,069
03/08/26 A$0.1450 0.00% 252,423